Abstract
BackgroundBrain-derived neurotrophic factor (BDNF) plays an important role in neuronal plasticity, and its dysregulation has been associated with the pathogenesis of mood and anxiety disorders. Prolactin (PRL) is a pituitary hormone which is also produced as a cytokine by immune cells and could be a neurotrophic factor regulating the functional activity of stress-related mechanisms.AimTo investigate the possible relationship between depressive state and BDNF and PRL genotypes or levels with special reference to severity of depression.MethodsParticipants of 18–70 years with a clinical diagnosis of depressive disorder of at least moderate severity were included. These patients had not been treated with antidepressant drugs before admission to hospital during the preceding period of the last 6 months, and 54.5% had never been treated with antidepressant drugs during their entire life. The DNA was genotyped for rs1341239 within the prolactin and for rs6265, rs7124442, and rs11030104 within the BDNF gene. Rs11030104 violated the Hardy-Weinberg equilibrium distribution and was excluded from further analyses. BDNF and prolactin concentration was measured in serum by MAGPIX multiplex analyzer (Luminex, USA) using MILLIPLEX® MAP kit (Merck, Germany). Genetic associations were determined by sequentially regressing prolactin, BDNF, 17-items Hamilton's Depression (HAMD-17) and Clinical Global Impression scale, Severity (CGI-S) ratings, and depression (absent/present) on the available SNPs. Genetic associations were evaluated assuming an additive model.ResultsA total of 186 depressed patients (of which 169 were women) and 94 healthy controls (67 women) were genotyped. After excluding subjects without genetic information on all three study SNPs, 217 remained of whom 138 suffered from depression. Within depressed patients we observed an association of rs6265 with HAMD-17: mean difference (MD) 2.33 (95%CI 0.49; 4.16; p = 0.014) and CGI-S: MD 0.38 (95%CI 0.09; 0.66; p = 0.011). No significant association was observed between the prolactin SNP rs1341239 and prolactin levels. Similarly the mean differences of BDNF SNPs did not show an association with BDNF: rs6265 −0.042 ln(pg/ml) (95%CI −0.198; 0.113), and rs7124442 0.006 ln(pg/ml) (95%CI −0.117; 0.130). No other association reached statistical significance.ConclusionWe observed a significant association between BDNF gene variant rs6265 and the severity of depression in newly admitted, antidepressant treatment-free, depressed patients. Actual PRL and BDNF levels were not elevated sufficiently in depressed patients to reach statistical significance and were not associated with the studied genotypes.
Highlights
Brain-derived neurotrophic factor (BDNF), discovered in 1982 [1], is a member of the neurotrophin family, including nerve growth factor (NGF), neurotrophin-3 (NT-3), and neurotrophin-4 (NT-4) [2]
Within depressed patients we observed an association of rs6265 with HAMD-17: mean difference (MD) 2.33 (95%CI 0.49; 4.16; p = 0.014)
We found an association of rs6265 with the severity of depression according to the patient's HAMD-17 as well as CGI-S scores at admission to the hospital
Summary
Brain-derived neurotrophic factor (BDNF), discovered in 1982 [1], is a member of the neurotrophin family, including nerve growth factor (NGF), neurotrophin-3 (NT-3), and neurotrophin-4 (NT-4) [2]. Pharmacological and behavioral studies have linked the dysregulation of BDNF to major psychiatric and neurological disorders, including mood and anxiety disorders [3,4,5]. BDNF genotype and expression can be expected to modulate BDNF levels and/or its neuroplastic effects and may, affect the vulnerability to develop mood disorders. In spite of these functional consequences, systematic reviews of the results of association studies suggest that this BDNF genotype does neither exert a major influence on the development of depression [7,8,9], nor on the serum BDNF levels [10]. Brain-derived neurotrophic factor (BDNF) plays an important role in neuronal plasticity, and its dysregulation has been associated with the pathogenesis of mood and anxiety disorders. Prolactin (PRL) is a pituitary hormone which is produced as a cytokine by immune cells and could be a neurotrophic factor regulating the functional activity of stress-related mechanisms
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have